Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
The Benefits of Dual Inhibition of 5alpha Reductase
European Urology Supplements, 11/29/06
Bob Djavana, et al. - In humans, androgens balance cell proliferation and apoptosis, ensuring normal growth and development of the prostate, but also driving pathologic gland enlargement in benign prostatic hyperplasia (BPH) and prostate cancer. The two main androgens are testosterone and dihydrotestosterone (DHT). Reducing testosterone levels results in significant sexual side-effects, whereas reducing DHT does not result in any major safety or tolerability issues...Dutasteride demonstrates sustained improvement in symptom score and maximal flow rate with no increase in prostate volume up to 4 yr
| Previous Article | Next Article |
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
Influence of palm oil on doxorubicin induced cytotoxicity in normal and tumor cell cultures
Phytotherapy Research, 06/05/09
Proinflammatory cytokines in patients with neuropathic pain treated with Tramadol
Revista Brasileira de Anestesiologia, 06/04/09
Cytotoxic Activities of Physalis minima L. Chloroform Extract on Human Lung Adenocarcinoma NCI-H23 Cell Lines by Induction of Apoptosis
Evidence-based Complementary and Alternative Medicine , 06/22/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
A double-blind, randomized, saline-controlled study of the efficacy and safety of Euflexxa® for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial)
Seminars in Arthritis and Rheumatism, 06/29/09
Prevention of vertebral fractures in osteoporosis: Mixed treatment comparison of bisphosphonate therapies
Current Medical Research and Opinion, 06/23/09
Trends in RA patients' adherence to subcutaneous anti-TNF therapies and costs
Current Medical Research and Opinion, 06/24/09
Article Search
Sponsor


See Latest Articles


